Insulet (PODD) official guidance

Insulet (PODD) official earnings guidance and management outlook. Each figure management stated is shown with its revisions and the source quote.

See the full Filings Intelligence suite
PODDINSULET CORPFY2026 · ends 2026-12-31
7 metrics1 lowered4 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC70Mmaintained-2.6% vs FY2025
We continue to expect approximately 70 million shares outstanding and now anticipate adjusted EPS growth of at least 30% for the full year.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-02-19 05:01:52 UTC70Mnew-2.6% vs FY2025
Based on our current share count and repurchase plans, we expect the 2026 ending balance of our diluted share count to be around 70 million shares.
PODD · transcript · Q4 FY2025
2026-02-19 05:00:00 UTCOpen source
2026-08-06 04:01:27 UTC20% – 21%lowered -4.7%
For low operating income, we expect approximately $40 million of net interest expense and a non-GAAP tax rate of 20% to 21%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-05-07 04:01:29 UTC21% – 22%lowered -4.4%
We now expect our 2026 non-GAAP tax rate to be in the range of 21%-22%, reflecting the lower Q1 tax rate, favorable mix of earnings, and improved utilization of foreign tax credits.
PODD · transcript · Q1 FY2026
2026-05-07 04:00:00 UTCOpen source
2026-02-19 05:01:52 UTC22% – 23%new
We expect 2026 net interest expense to total approximately $40 million, primarily due to lower interest income, and we expect 2026 non-GAAP tax rate to be in the range of 22%-23%.
PODD · transcript · Q4 FY2025
2026-02-19 05:00:00 UTCOpen source
2026-08-06 04:01:27 UTCat least 30%30% vs FY2025
We continue to expect approximately 70 million shares outstanding and now anticipate adjusted EPS growth of at least 30% for the full year.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTCat least 30%30% vs FY2025
| Adjusted EPS Growth1 | | >30% | >25% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-07 04:01:29 UTCat least 25%25% vs FY2025
Based on these factors, we continue to expect adjusted EPS to increase by more than 25% in 2026.
PODD · transcript · Q1 FY2026
2026-05-07 04:00:00 UTCOpen source
2026-05-06 11:07:16 UTCat least 25%25% vs FY2025
| Adjusted EPS Growth1 | | >25% | >25% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTCat least 25%new25% vs FY2025
| Adjusted EPS Growth1 | | >25% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
2026-08-06 04:01:27 UTCdown modestly from 2025 levels
We expect free cash flow to be down modestly from 2025 levels, which reflects the impact from the medical device correction, but still healthy, supported by strong earnings growth and margin expansion, and offset by increasing capital expenditures associated with our manufacturing expansion plans.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-05-07 04:01:29 UTCapproximately flat from 2025 levels
We expect free cash flow to be approximately flat from 2025 levels, supported by robust growth and continued margin expansion, partially offset by a ramp-up in capital expenditures to support our continued global manufacturing expansion plans.
PODD · transcript · Q1 FY2026
2026-05-07 04:00:00 UTCOpen source
2026-02-19 05:01:52 UTCapproximately flat from 2025 levelsnew
We expect free cash flow to be approximately flat from 2025 levels, supported by robust growth and continued margin expansion, partially offset by a ramp-up in capital expenditures to support our continued global manufacturing expansion plans.
PODD · transcript · Q4 FY2025
2026-02-19 05:00:00 UTCOpen source
2026-08-06 04:01:27 UTC$40Mmaintained
For low operating income, we expect approximately $40 million of net interest expense and a non-GAAP tax rate of 20% to 21%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-05-07 04:01:29 UTC$40Mmaintained
We expect 2026 net interest expense to total approximately $40 million, an increase of approximately $15 million, primarily due to lower interest income.
PODD · transcript · Q1 FY2026
2026-05-07 04:00:00 UTCOpen source
2026-02-19 05:01:52 UTC$40Mnew
We expect 2026 net interest expense to total approximately $40 million, primarily due to lower interest income, and we expect 2026 non-GAAP tax rate to be in the range of 22%-23%.
PODD · transcript · Q4 FY2025
2026-02-19 05:00:00 UTCOpen source
2026-08-06 04:01:27 UTC100 bpsmaintained100 bps vs FY2025
We continue to expect adjusted operating margin to expand by approximately 100 basis points annually and adjusted EPS to grow at a CAGR of more than 25%, while continuing to generate strong free cash flow.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC100 bpsmaintained100 bps vs FY2025
| Adjusted Operating Margin1 | | ~100 bps YoY expansion | ~100 bps YoY expansion |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC100 bpsmaintained100 bps vs FY2025
| Adjusted Operating Margin1 | | ~100 bps YoY expansion | ~100 bps YoY expansion |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC100 bpsnew100 bps vs FY2025
| Adjusted Operating Margin1 | | | ~100 bps YoY expansion |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
2026-08-06 04:01:27 UTC30% – 32%maintained30% – 32% vs FY2025
We are increasing our full year outlook for international Omnipod to 30% to 32% on a constant currency basis, reflecting strong performance year-to-date and continued momentum across our markets.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC30% – 32%raised +14.8%30% – 32% vs FY2025
| International Omnipod | 33% - 35% | 3% | 30% - 32% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC26% – 28%raised +8.0%26% – 28% vs FY2025
| International Omnipod | 29% - 31% | 3% | 26% - 28% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC24% – 26%new24% – 26% vs FY2025
| International | 27% - 29% | 3% | 24% - 26% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
PODDINSULET CORPQ3 FY2026 · ends 2026-09-30
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC28% – 30%maintained28% – 30% vs Q3 FY2025
In the U.S., we expect Omnipod revenue growth of 14% to 16%, and internationally, we expect Omnipod revenue growth of 28% to 30%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC28% – 30%new28% – 30% vs Q3 FY2025
| International Omnipod | 26% - 28% | (2)% | 28% - 30% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
PODDINSULET CORPFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC21% – 23%maintained21% – 23% vs FY2025
Taking these assumptions into account, we now expect full year constant currency revenue growth of 20% to 22% for total company and 21% to 23% for total Omnipod.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC21% – 23%lowered -4.3%21% – 23% vs FY2025
| Total Omnipod | 22% - 24% | 1% | 21% - 23% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC22% – 24%raised +4.5%22% – 24% vs FY2025
| Total Omnipod | 23% - 25% | 1% | 22% - 24% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC21% – 23%new21% – 23% vs FY2025
| Total Omnipod Products | 22% - 24% | 1% | 21% - 23% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
PODDINSULET CORPQ3 FY2026 · ends 2026-09-30
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC18% – 20%maintained18% – 20% vs Q3 FY2025
Turning to the third quarter, we expect Omnipod revenue growth of 18% to 20% and total company revenue growth of 17.5% to 19.5%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC18% – 20%new18% – 20% vs Q3 FY2025
| Total Omnipod | 17.5% - 19.5% | (0.5)% | 18% - 20% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
PODDINSULET CORPFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC17% – 19%maintained17% – 19% vs FY2025
For the U.S., we now expect Omnipod revenue growth of 17% to 19% for the full year.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC17% – 19%lowered -14.3%17% – 19% vs FY2025
| U.S. Omnipod | 17% - 19% | —% | 17% - 19% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC20% – 22%maintained20% – 22% vs FY2025
| U.S. Omnipod | 20% - 22% | —% | 20% - 22% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC20% – 22%new20% – 22% vs FY2025
| U.S. | 20% - 22% | —% | 20% - 22% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
PODDINSULET CORPQ3 FY2026 · ends 2026-09-30
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC14% – 16%maintained14% – 16% vs Q3 FY2025
In the U.S., we expect Omnipod revenue growth of 14% to 16%, and internationally, we expect Omnipod revenue growth of 28% to 30%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC14% – 16%new14% – 16% vs Q3 FY2025
| U.S. Omnipod | 14% - 16% | —% | 14% - 16% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
PODDINSULET CORPFY2026 · ends 2026-12-31
1 metric1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC20% – 22%maintained20% – 22% vs FY2025
Taking these assumptions into account, we now expect full year constant currency revenue growth of 20% to 22% for total company and 21% to 23% for total Omnipod.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC20% – 22%lowered -4.5%20% – 22% vs FY2025
| Total | 21% - 23% | 1% | 20% - 22% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC21% – 23%raised +4.8%21% – 23% vs FY2025
| Total | 22% - 24% | 1% | 21% - 23% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC20% – 22%new20% – 22% vs FY2025
| Total | 21% - 23% | 1% | 20% - 22% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
PODDINSULET CORPFY2027 · ends 2027-12-31
1 metric1 new
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTCgrowth consistent with or better than that exit ratenew
Our objective in 2027 is to deliver growth consistent with or better than that exit rate, supported by new product launches and the benefits of our sales force expansion.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
PODDINSULET CORPFY2026
1 metric1 new
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTCmid-teensnew14% – 16%
Based on the midpoint of our third quarter and full year guidance ranges, we expect total company constant currency revenue growth to exit 2026 in the mid-teens.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
PODDINSULET CORPQ3 FY2026 · ends 2026-09-30
2 metrics1 new1 maintained
earnings call · 2026-08-06 04:01:27 UTC
2026-08-06 04:01:27 UTC17.5% – 19.5%maintained17.5% – 19.5% vs Q3 FY2025
Turning to the third quarter, we expect Omnipod revenue growth of 18% to 20% and total company revenue growth of 17.5% to 19.5%.
PODD · transcript · Q2 FY2026
2026-08-06 04:00:00 UTCOpen source
2026-08-05 11:06:11 UTC17.5% – 19.5%new17.5% – 19.5% vs Q3 FY2025
| Total | 17% - 19% | (0.5)% | 17.5% - 19.5% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-08-05 11:06:11 UTC-20%new-20% vs Q3 FY2025
| Drug Delivery | ~(20%) | —% | ~(20%) |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
PODDINSULET CORPFY2026 · ends 2026-12-31
1 metric1 raised
earnings release · 2026-08-05 11:06:11 UTC
2026-08-05 11:06:11 UTC33% – 35%raised +13.3%33% – 35% vs FY2025
| International Omnipod | 33% - 35% | 3% | 30% - 32% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC29% – 31%raised +7.1%29% – 31% vs FY2025
| International Omnipod | 29% - 31% | 3% | 26% - 28% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC27% – 29%new27% – 29% vs FY2025
| International | 27% - 29% | 3% | 24% - 26% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source
PODDINSULET CORPQ3 FY2026 · ends 2026-09-30
1 metric1 new
earnings release · 2026-08-05 11:06:11 UTC
2026-08-05 11:06:11 UTC26% – 28%new26% – 28% vs Q3 FY2025
| International Omnipod | 26% - 28% | (2)% | 28% - 30% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
PODDINSULET CORPFY2026 · ends 2026-12-31
1 metric1 lowered
earnings release · 2026-08-05 11:06:11 UTC
2026-08-05 11:06:11 UTC17% – 19%lowered -14.3%17% – 19% vs FY2025
| U.S. Omnipod | 17% - 19% | —% | 17% - 19% |
PODD · EX-99.1 · Q2 FY2026
2026-08-05 11:04:50 UTCOpen source
2026-05-06 11:07:16 UTC20% – 22%maintained20% – 22% vs FY2025
| U.S. Omnipod | 20% - 22% | —% | 20% - 22% |
PODD · EX-99.1 · Q1 FY2026
2026-05-06 11:05:39 UTCOpen source
2026-02-18 12:07:27 UTC20% – 22%new20% – 22% vs FY2025
| U.S. | 20% - 22% | —% | 20% - 22% |
PODD · EX-99.1 · Q4 FY2025
2026-02-18 12:05:33 UTCOpen source